$17.78
2.24%
Nasdaq, Nov 28, 10:00 pm CET
ISIN
US36322Q1076
Symbol
GLTO

Galecto Inc Stock price

$17.78
+10.62 148.32% 1M
+14.78 492.67% 6M
+13.13 282.37% YTD
+12.27 222.69% 1Y
-18.72 51.29% 3Y
-364.97 95.35% 5Y
-357.22 95.26% 10Y
-357.22 95.26% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
+0.39 2.24%
ISIN
US36322Q1076
Symbol
GLTO
Industry

Key metrics

Basic
Market capitalization
$23.6m
Enterprise Value
$16.0m
Net debt
positive
Cash
$7.6m
Shares outstanding
1.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
3.0
Financial Health
Equity Ratio
92.4%
Return on Equity
-135.4%
ROCE
-146.3%
ROIC
-678.9%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-12.1m | $-63.6m
EBIT
$-11.9m | $-24.1m
Net Income
$-15.8m | $-15.0m
Free Cash Flow
$-12.2m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
39.3% | -277.1%
EBIT
41.0% | -42.4%
Net Income
25.2% | 30.1%
Free Cash Flow
51.4%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-11.9
FCF per Share
$-9.2
Short interest
21.8%
Employees
5
Rev per Employee
$0.0
Show more

Is Galecto Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Galecto Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Galecto Inc forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Galecto Inc forecast:

Hold
50%
Sell
50%

Financial data from Galecto Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 7.32 7.32
39% 39%
-
- Research and Development Expense 4.57 4.57
44% 44%
-
-12 -12
39% 39%
-
- Depreciation and Amortization -0.20 -0.20
180% 180%
-
EBIT (Operating Income) EBIT -12 -12
41% 41%
-
Net Profit -16 -16
25% 25%
-

In millions USD.

Don't miss a Thing! We will send you all news about Galecto Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galecto Inc Stock News

Positive
Invezz
19 days ago
Two obscure US biotech and medtech names – Galecto Inc (NASDAQ: GLTO) and Movano Inc (NASDAQ: MOVE) – stunned markets today with explosive rallies, each surging roughly 300%. While the gains were triggered by company-specific news, the magnitude of the moves has drawn speculative interest from retail traders and momentum chasers.
Neutral
GlobeNewsWire
19 days ago
Acquisition of Damora and concurrent oversubscribed $285 million private investment positions the company to advance potentially best-in-class portfolio to improve outcomes in patients with Myeloproliferative Neoplasms
Neutral
GlobeNewsWire
23 days ago
BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced its operating and financial results for the quarter ended September 30, 2025.
More Galecto Inc News

Company Profile

Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211. The company was founded by Ulf Nilsson, Hakon Leffler, Tariq Sethi, and Hans T. Schambye in 2011 and is headquartered in Copenhagen, Denmark.

Head office United States
CEO Hans Schambye
Employees 5
Founded 2011
Website galecto.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today